Literature DB >> 21102640

Is Huntington disease a developmental disorder?

Sandrine Humbert1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21102640      PMCID: PMC2999873          DOI: 10.1038/embor.2010.182

Source DB:  PubMed          Journal:  EMBO Rep        ISSN: 1469-221X            Impact factor:   8.807


× No keyword cloud information.
  8 in total

1.  Mutant huntingtin-impaired degradation of beta-catenin causes neurotoxicity in Huntington's disease.

Authors:  Juliette D Godin; Ghislaine Poizat; Miriam A Hickey; Florence Maschat; Sandrine Humbert
Journal:  EMBO J       Date:  2010-06-08       Impact factor: 11.598

2.  Testicular degeneration in Huntington disease.

Authors:  Jeremy M Van Raamsdonk; Zoe Murphy; David M Selva; Reza Hamidizadeh; Jacqueline Pearson; Asa Petersén; Maria Björkqvist; Cameron Muir; Ian R Mackenzie; Geoffrey L Hammond; A Wayne Vogl; Michael R Hayden; Blair R Leavitt
Journal:  Neurobiol Dis       Date:  2007-01-27       Impact factor: 5.996

3.  Mammalian Pins is a conformational switch that links NuMA to heterotrimeric G proteins.

Authors:  Quansheng Du; Ian G Macara
Journal:  Cell       Date:  2004-11-12       Impact factor: 41.582

4.  Huntingtin is required for mitotic spindle orientation and mammalian neurogenesis.

Authors:  Juliette D Godin; Kelly Colombo; Maria Molina-Calavita; Guy Keryer; Diana Zala; Bénédicte C Charrin; Paula Dietrich; Marie-Laure Volvert; François Guillemot; Ioannis Dragatsis; Yohanns Bellaiche; Frédéric Saudou; Laurent Nguyen; Sandrine Humbert
Journal:  Neuron       Date:  2010-08-12       Impact factor: 17.173

5.  Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules.

Authors:  Laurent R Gauthier; Bénédicte C Charrin; Maria Borrell-Pagès; Jim P Dompierre; Hélène Rangone; Fabrice P Cordelières; Jan De Mey; Marcy E MacDonald; Volkmar Lessmann; Sandrine Humbert; Frédéric Saudou
Journal:  Cell       Date:  2004-07-09       Impact factor: 41.582

6.  Huntingtin interacting proteins are genetic modifiers of neurodegeneration.

Authors:  Linda S Kaltenbach; Eliana Romero; Robert R Becklin; Rakesh Chettier; Russell Bell; Amit Phansalkar; Andrew Strand; Cameron Torcassi; Justin Savage; Anthony Hurlburt; Guang-Ho Cha; Lubna Ukani; Cindy Lou Chepanoske; Yuejun Zhen; Sudhir Sahasrabudhe; James Olson; Cornelia Kurschner; Lisa M Ellerby; John M Peltier; Juan Botas; Robert E Hughes
Journal:  PLoS Genet       Date:  2007-05-11       Impact factor: 5.917

7.  Huntingtin facilitates dynein/dynactin-mediated vesicle transport.

Authors:  Juliane P Caviston; Jennifer L Ross; Sheila M Antony; Mariko Tokito; Erika L F Holzbaur
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-04       Impact factor: 11.205

8.  Mouse mutant embryos lacking huntingtin are rescued from lethality by wild-type extraembryonic tissues.

Authors:  I Dragatsis; A Efstratiadis; S Zeitlin
Journal:  Development       Date:  1998-04       Impact factor: 6.868

  8 in total
  16 in total

Review 1.  Clinical Trials in a Dish: The Potential of Pluripotent Stem Cells to Develop Therapies for Neurodegenerative Diseases.

Authors:  Kelly M Haston; Steven Finkbeiner
Journal:  Annu Rev Pharmacol Toxicol       Date:  2015-10-28       Impact factor: 13.820

2.  Intrinsic mutant HTT-mediated defects in oligodendroglia cause myelination deficits and behavioral abnormalities in Huntington disease.

Authors:  Costanza Ferrari Bardile; Marta Garcia-Miralles; Nicholas S Caron; Nirmala Arul Rayan; Sarah R Langley; Nathan Harmston; Ana Maria Rondelli; Roy Tang Yi Teo; Sabine Waltl; Lisa M Anderson; Han-Gyu Bae; Sangyong Jung; Anna Williams; Shyam Prabhakar; Enrico Petretto; Michael R Hayden; Mahmoud A Pouladi
Journal:  Proc Natl Acad Sci U S A       Date:  2019-04-23       Impact factor: 11.205

3.  LIN28A loss of function is associated with Parkinson's disease pathogenesis.

Authors:  Mi-Yoon Chang; Boram Oh; Jang-Eun Choi; Yanuar Alan Sulistio; Hye-Ji Woo; Ayoung Jo; Jinil Kim; Eun-Hee Kim; Seung Won Kim; Jungwook Hwang; Jungyun Park; Jae-Jin Song; Oh-Chan Kwon; Hyongbum Henry Kim; Young-Hoon Kim; Joo Yeon Ko; Jun Young Heo; Min Joung Lee; Moses Lee; Murim Choi; Sun Ju Chung; Hyun-Seob Lee; Sang-Hun Lee
Journal:  EMBO J       Date:  2019-11-21       Impact factor: 11.598

Review 4.  Mechanism(s) of alteration of micro RNA expressions in Huntington's disease and their possible contributions to the observed cellular and molecular dysfunctions in the disease.

Authors:  Mithun Sinha; Saikat Mukhopadhyay; Nitai P Bhattacharyya
Journal:  Neuromolecular Med       Date:  2012-05-13       Impact factor: 3.843

Review 5.  Cell-Autonomous and Non-cell-Autonomous Pathogenic Mechanisms in Huntington's Disease: Insights from In Vitro and In Vivo Models.

Authors:  Jordi Creus-Muncunill; Michelle E Ehrlich
Journal:  Neurotherapeutics       Date:  2019-10       Impact factor: 7.620

6.  Comparison of modules of wild type and mutant Huntingtin and TP53 protein interaction networks: implications in biological processes and functions.

Authors:  Mahashweta Basu; Nitai P Bhattacharyya; Pradeep K Mohanty
Journal:  PLoS One       Date:  2013-05-31       Impact factor: 3.240

7.  DISC1 and Huntington's disease--overlapping pathways of vulnerability to neurological disorder?

Authors:  Ruth Boxall; David J Porteous; Pippa A Thomson
Journal:  PLoS One       Date:  2011-01-26       Impact factor: 3.240

8.  MicroRNAs located in the Hox gene clusters are implicated in huntington's disease pathogenesis.

Authors:  Andrew G Hoss; Vinay K Kartha; Xianjun Dong; Jeanne C Latourelle; Alexandra Dumitriu; Tiffany C Hadzi; Marcy E Macdonald; James F Gusella; Schahram Akbarian; Jiang-Fan Chen; Zhiping Weng; Richard H Myers
Journal:  PLoS Genet       Date:  2014-02-27       Impact factor: 5.917

Review 9.  Induced Pluripotent Stem Cells in Huntington's Disease Research: Progress and Opportunity.

Authors:  Adelaide Tousley; Kimberly B Kegel-Gleason
Journal:  J Huntingtons Dis       Date:  2016-06-28

10.  Huntington's Disease as Neurodevelopmental Disorder: Altered Chromatin Regulation, Coding, and Non-Coding RNA Transcription.

Authors:  Emanuela Kerschbamer; Marta Biagioli
Journal:  Front Neurosci       Date:  2016-01-13       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.